PETMED EXPRESS INCPETSEarnings & Financial Report
Nasdaq · veterinary medicine
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
PETS Q3 2026 Key Financial Metrics
Revenue
$40.7M
Gross Profit
$9.5M
Operating Profit
$-10.5M
Net Profit
$-10.6M
Gross Margin
23.3%
Operating Margin
-25.7%
Net Margin
-26.0%
YoY Growth
-23.3%
EPS
$-0.50
Financial Flow
PETMED EXPRESS INC Q3 2026 Financial Summary
PETMED EXPRESS INC reported revenue of $40.7M for Q3 2026, with a net profit of $-10.6M (-26.0% margin). Cost of goods sold was $31.2M, operating expenses totaled $19.9M.
Key Financial Metrics
| Total Revenue | $40.7M |
|---|---|
| Net Profit | $-10.6M |
| Gross Margin | 23.3% |
| Operating Margin | -25.7% |
| Report Period | Q3 2026 |
PETMED EXPRESS INC Annual Revenue by Year
PETMED EXPRESS INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $227.0M).
| Year | Annual Revenue |
|---|---|
| 2025 | $227.0M |
| 2024 | $274.1M |
| 2023 | $247.6M |
| 2022 | $273.4M |
Income Statement
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $59.5M | $68.0M | $59.6M | $53.0M | $46.5M | $51.2M | $44.4M | $40.7M |
| YoY Growth | -0.4% | -13.2% | -16.1% | -18.9% | -22.0% | -24.7% | -25.5% | -23.3% |
Balance Sheet
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $169.9M | $152.7M | $146.0M | $144.8M | $148.7M | $109.8M | $100.3M | $88.0M |
| Liabilities | $73.2M | $59.2M | $49.6M | $48.6M | $63.6M | $58.3M | $57.2M | $55.2M |
| Equity | $96.7M | $93.5M | $96.4M | $96.2M | $85.1M | $51.5M | $43.1M | $32.8M |
Cash Flow
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $7.1M | $-8.5M | $7.4M | $-1.2M | $7.0M | $-12.3M | $-2.2M | $-9.2M |